Biocon Limited - Financial Analysis Review
Summary
Biocon Limited (Biocon) is a fully integrated healthcare company engaged in the manufacturing of biopharmaceutical products through using fermentation-based technology. The company produces wide range of active pharmaceutical ingredients (APIs), branded formulations and biologicals. Its core therapeutic areas include anti-diabetic, cardiovascular, anti-inflammatory, anti-obesity, hemostatic, hepatoprotective, gastro-intestinal, neutraceuticals, digestive-aid enzymes, immunosuppressants and anti-oxidants.
Global Markets Direct’s "Biocon Limited - Financial Analysis Review” is an in-depth business and financial analysis of Biocon Limited. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the financial analysis of the company. This highlights the company’s ratio analysis for the past five years.
And More inside the report…
Recent Developments
Dec 10, 2009: Biocon, HCG Group of Hospitals Collaborate To Fight Cervical Cancer
Oct 26, 2009: Biocon Reports Profits Of INR74 crore
Sep 11, 2009: Biocon Seals Development, Commercialisation Agreement With Amylin
Scope
- Provides key company information for business intelligence needs
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick “one-stop-shop” to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with insight into the companies’ financial performance.
Report Highlights
The following companies are the major competitors of Biocon Limited:
Novartis AG
Sun Pharmaceutical Industries Limited
Bharat Biotech International Limited
[Studien Infos ausblenden]
